First Hawaiian Bank Sarepta Therapeutics, Inc. Transaction History

First Hawaiian Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 15, 2019	SELL	$112.21 - $151.95 $4,039 - $5,470	-36 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$106.67 - $151.68 $17,707 - $25,178	-166 Reduced 82.18%	36 $4,000
Q4 2018 Jan 11, 2019	SELL	$97.32 - $148.76 $6,812 - $10,413	-70 Reduced 25.74%	202 $22,000
Q3 2018 Oct 16, 2018	BUY	$115.31 - $161.51 $31,364 - $43,930	272 New	272 $44,000

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.